APYX
Price
$1.39
Change
-$0.03 (-2.11%)
Updated
Jan 17 closing price
Capitalization
47.46M
53 days until earnings call
CSBTF
Price
$26.07
Change
-$1.53 (-5.54%)
Updated
Jan 16 closing price
Capitalization
99.14M
Ad is loading...

APYX vs CSBTF

Header iconAPYX vs CSBTF Comparison
Open Charts APYX vs CSBTFBanner chart's image
Apyx Medical
Price$1.39
Change-$0.03 (-2.11%)
Volume$16.51K
Capitalization47.46M
Kuros Bioscience
Price$26.07
Change-$1.53 (-5.54%)
Volume$362
Capitalization99.14M
APYX vs CSBTF Comparison Chart
Loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSBTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APYX vs. CSBTF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Hold and CSBTF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (APYX: $1.39 vs. CSBTF: $26.07)
Brand notoriety: APYX and CSBTF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: APYX: 28% vs. CSBTF: 27%
Market capitalization -- APYX: $47.46M vs. CSBTF: $99.14M
APYX [@Medical Specialties] is valued at $47.46M. CSBTF’s [@Medical Specialties] market capitalization is $99.14M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileCSBTF’s FA Score has 1 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • CSBTF’s FA Score: 1 green, 4 red.
According to our system of comparison, CSBTF is a better buy in the long-term than APYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 2 TA indicator(s) are bullish while CSBTF’s TA Score has 4 bullish TA indicator(s).

  • APYX’s TA Score: 2 bullish, 2 bearish.
  • CSBTF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CSBTF is a better buy in the short-term than APYX.

Price Growth

APYX (@Medical Specialties) experienced а -12.58% price change this week, while CSBTF (@Medical Specialties) price change was -5.54% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

APYX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSBTF($99.1M) has a higher market cap than APYX($47.5M). CSBTF YTD gains are higher at: 15.507 vs. APYX (-12.025). CSBTF has higher annual earnings (EBITDA): -8.84M vs. APYX (-18.11M). APYX has more cash in the bank: 43.7M vs. CSBTF (24.1M). CSBTF has less debt than APYX: CSBTF (1.91M) vs APYX (38.5M). APYX has higher revenues than CSBTF: APYX (52.3M) vs CSBTF (18M).
APYXCSBTFAPYX / CSBTF
Capitalization47.5M99.1M48%
EBITDA-18.11M-8.84M205%
Gain YTD-12.02515.507-78%
P/E RatioN/AN/A-
Revenue52.3M18M291%
Total Cash43.7M24.1M181%
Total Debt38.5M1.91M2,013%
FUNDAMENTALS RATINGS
APYX vs CSBTF: Fundamental Ratings
APYX
CSBTF
OUTLOOK RATING
1..100
5950
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
10013
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
5935
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSBTF's Valuation (57) in the null industry is in the same range as APYX (58) in the Medical Specialties industry. This means that CSBTF’s stock grew similarly to APYX’s over the last 12 months.

CSBTF's Profit vs Risk Rating (13) in the null industry is significantly better than the same rating for APYX (100) in the Medical Specialties industry. This means that CSBTF’s stock grew significantly faster than APYX’s over the last 12 months.

CSBTF's SMR Rating (94) in the null industry is in the same range as APYX (98) in the Medical Specialties industry. This means that CSBTF’s stock grew similarly to APYX’s over the last 12 months.

CSBTF's Price Growth Rating (35) in the null industry is in the same range as APYX (59) in the Medical Specialties industry. This means that CSBTF’s stock grew similarly to APYX’s over the last 12 months.

CSBTF's P/E Growth Rating (100) in the null industry is in the same range as APYX (100) in the Medical Specialties industry. This means that CSBTF’s stock grew similarly to APYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APYXCSBTF
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
57%
Stochastic
ODDS (%)
N/A
Bearish Trend 12 days ago
38%
Momentum
ODDS (%)
Bearish Trend 12 days ago
85%
Bullish Trend 12 days ago
65%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
83%
Bullish Trend 12 days ago
32%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
33%
Advances
ODDS (%)
Bullish Trend 14 days ago
85%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
58%
Aroon
ODDS (%)
Bullish Trend 12 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSBTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZTEK1.180.20
+20.40%
Zentek Ltd
MLAB139.612.45
+1.79%
Mesa Laboratories
HBM8.59-0.05
-0.58%
Hudbay Minerals
NTRA158.36-10.14
-6.02%
Natera
AEMD0.66-0.05
-7.10%
Aethlon Medical

APYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
-2.11%
CORBF - APYX
36%
Loosely correlated
-15.83%
MKEAF - APYX
33%
Loosely correlated
N/A
AVGR - APYX
27%
Poorly correlated
+1.71%
ESTA - APYX
26%
Poorly correlated
-0.23%
WRBY - APYX
24%
Poorly correlated
-6.25%
More

CSBTF and

Correlation & Price change

A.I.dvisor tells us that CSBTF and APYX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBTF and APYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSBTF
1D Price
Change %
CSBTF100%
N/A
APYX - CSBTF
22%
Poorly correlated
-2.11%
DIZTF - CSBTF
4%
Poorly correlated
N/A
CHEOY - CSBTF
2%
Poorly correlated
+0.16%
CLPBF - CSBTF
2%
Poorly correlated
+5.20%
CNVVF - CSBTF
1%
Poorly correlated
N/A
More